Skip to content

Development of socket Fit material preventing blood flow during Dental procedures.

DEVELOPMENT OF BIOACTIVE SOCKET FIT HEMOSTAT CUM GRAFT FOR DENTAL APPLICATIONS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038175
Enrollment
10
Registered
2021-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K041- Necrosis of pulp

Interventions

Intervention1: Hemostat made up of gelatine and strontium bioglass: Placement of socket fit hemostat containing gelatine and strontium bioglass in the extraction socket for 1,2,3months Control Interv

Sponsors

Biotechnology Industry Research Assistance Council BIRAC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing extraction for pulp and periapical diseases.

Exclusion criteria

Exclusion criteria: Patients with any systemic illness will be excluded.

Design outcomes

Primary

MeasureTime frame
Hemostat is expected to exhibit improved hemostasis, antimicrobial efficacy and bone regenerating capability.Timepoint: 1,2,3 months

Secondary

MeasureTime frame
Hemostat is expected to exhibit better bone regenerating capability.Timepoint: 1,2,3 months

Countries

India

Contacts

Public ContactDr Ramya Ramadoss

SRM DENTAL COLLEGE

ramyaresearch26@gmail.com8825876700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026